Jacques Ferlay
Auto-generated profile, based on publicly available information

Jacques Ferlay

Cancer Surveillance Branch International Agency for Research on Cancer Lyon France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2018 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JFJ. Ferlay
J. Ferlay
MCM. Colombet
M. Colombet
ISI. Soerjomataram
I. Soerjomataram
CMC. Mathers
C. Mathers
DPDonald Maxwell Parkin
Donald Maxwell Parkin
FBF. Bray
F. Bray

5 April 2021 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JFJacques Ferlay
Jacques Ferlay
MCMurielle Colombet
Murielle Colombet
ISIsabelle Soerjomataram
Isabelle Soerjomataram
DPDonald Maxwell Parkin
Donald Maxwell Parkin
MPMarion Piñeros
Marion Piñeros
FBFreddie Bray
Freddie Bray

1 April 2013 in European Journal of Cancer
Verified
Journal Article
Open access
JFJ. Ferlay
J. Ferlay
ESE. Steliarova-Foucher
E. Steliarova-Foucher
JLJ. Lortet-Tieulent
J. Lortet-Tieulent
SRS. Rosso
S. Rosso
JCJ.W.W. Coebergh
J.W.W. Coebergh
FBF. Bray
F. Bray
Cancer incidence and mortality estimates for 25 cancers are presented for the 40 countries in the four United Nations-defined areas of Europe and for the European Union (EU-27) for 2012. We used statistical models to estimate national incidence and mortality rates in 2012 from recently-published data, predicting incidence and mortality rates for the year 2012 from recent trends, wherever possible. The estimated rates in 2012 were applied to the corresponding population estimates to obtain the estimated numbers of new cancer cases and deaths in Europe in 2012. There were an estimated 3.45 million new cases of cancer (excluding non-melanoma skin cancer) and 1.75 million deaths from cancer in Europe in 2012. The most common cancer sites were cancers of the female breast (464,000 cases), followed by colorectal (447,000), prostate (417,000) and lung (410,000). These four cancers represent half of the overall burden of cancer in Europe. The most common causes of death from cancer were cancers of the lung (353,000 deaths), colorectal (215,000), breast (131,000) and stomach (107,000). In the European Union, the estimated numbers of new cases of cancer were approximately 1.4 million in males and 1.2 million in females, and around 707,000 men and 555,000 women died from cancer in the same year. These up-to-date estimates of the cancer burden in Europe alongside the description of the varying distribution of common cancers at both the regional and country level provide a basis for establishing priorities to cancer control actions in Europe. The important role of cancer registries in disease surveillance and in planning and evaluating national cancer plans is becoming increasingly recognised, but needs to be further advocated. The estimates and software tools for further analysis (EUCAN 2012) are available online as part of the European Cancer Observatory (ECO) (http://eco.iarc.fr).

1 November 2018 in European Journal of Cancer
Verified
Journal Article
Closed access
JFJ. Ferlay
J. Ferlay
MCM. Colombet
M. Colombet
ISI. Soerjomataram
I. Soerjomataram
TDT. Dyba
T. Dyba
GRG. Randi
G. Randi
FBF. Bray
F. Bray

1 November 2021 in European Journal of Cancer
Verified
Journal Article
Open access
TDTadeusz Dyba
Tadeusz Dyba
GRGiorgia Randi
Giorgia Randi
FBFreddie Bray
Freddie Bray
CMCarmen Martos
Carmen Martos
FGFrancesco Giusti
Francesco Giusti
MBManola Bettio
Manola Bettio
Europe is an important focus for compiling accurate and up-to-date world cancer statistics owing to its large share of the world's total cancer burden. This article presents incidence and mortality estimates for 25 major cancers across 40 individual countries within European areas and the European Union (EU-27) for the year 2020. The estimated national incidence and mortality rates are based on statistical methodology previously applied and verified using the most recently collected incidence data from 151 population-based cancer registries, mortality data and 2020 population estimates. Estimates reveal 4 million new cases of cancer (excluding non-melanoma skin cancer) and 1.9 million cancer-related deaths. The most common cancers are: breast in women (530,000 cases), colorectum (520,000), lung (480,000) and prostate (470,000). These four cancers account for half the overall cancer burden in Europe. The most common causes of cancer deaths are: lung (380,000), colorectal (250,000), breast (140,000) and pancreatic (130,000) cancers. In EU-27, the estimated new cancer cases are approximately 1.4 million in males and 1.2 million in females, with over 710,000 estimated cancer deaths in males and 560,000 in females. The 2020 estimates provide a basis for establishing priorities in cancer-control measures across Europe. The long-established role of cancer registries in cancer surveillance and the evaluation of cancer control measures remain fundamental in formulating and adapting national cancer plans and pan-European health policies. Given the estimates are built on recorded data prior to the onset of coronavirus disease 2019 (COVID-19), they do not take into account the impact of the pandemic.

5 November 2019 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JPJessica L. Petrick
Jessica L. Petrick
AFAndrea A. Florio
Andrea A. Florio
AZAriana Znaor
Ariana Znaor
DRDavid Ruggieri
David Ruggieri
MLMathieu Laversanne
Mathieu Laversanne
KMKatherine McGlynn
Katherine McGlynn